At Thompson’s we would like to reassure all our clients that as far as possible we are operating as normal. The health and safety of our staff and clients is our primary concern during this outbreak and as such we are reviewing the situation on a regular basis and will be adapting our working practices following government guidelines. However, we have had to make some minor changes to how we are doing things.

Following Government guidelines, we have temporarily closed all of our offices and our staff are now all working from home using secure technologies to ensure they are able to continue to progress with existing and new cases as normal. All face to face meetings have been cancelled, however we are continuing to hold these meetings via phone and video calls. All the team are contactable on their direct dial numbers and email should you need to speak with your solicitor, please do not hesitate to talk to us about anything during this time.

We know these are uncertain and unsettling times for many of our clients, and the wider population, and things might look a little different for the foreseeable future. But our focus remains on our dedication, knowledge and strength that we provide to all our clients. We will continue to provide updates over the coming days and weeks in accordance with official guidelines and to keep everyone informed of the situation.

As always, for any concerns, advice and updates on your case; Talk to Thompsons.

Click Here to Visit our Covid 19 Information Hub

Click Here to Read More About Covid 19 & Thompsons

Thompsons Solicitors Scotland
Thompsons Solicitors Scotland

Scotland is set to consolidate its status as one of the world's leading industrial disease research centres with the opening of an important new facility at the University of Glasgow.

The Glasgow Molecular Pathology Node will work with other leading Scottish research institutions - including the Stratified Medicine Scotland Innovation Centre, the Precision Medicine Catapult, the Scottish Genomes Partnership and the International Cancer Genome Consortium - to help develop treatments s patients according to their own physiology, rather than a blanket treatment approach.

The research centre, which has been made possible with a £3.4 million grant from the Engineering and Physical Sciences Research Council in conjunction with the Medical Research Council, will specialise in a discipline known as precision medicine, in which patients, including those suffering from industrial disease, have their genes, lifestyle and environment accounted for in a very calculated way; this contrasts with the more generalised diagnostic tests typical to less refined methodologies.

It is hoped that the University of Glasgow centre, which will be situated in the Laboratory Medicine Building at the Queen Elizabeth University Hospital, will not only provide more accurate diagnoses, but will also help develop better treatments for many industrial illnesses, including cancers such as mesothelioma.

"We now understand more about abnormalities in DNA and other molecules which occur in disease," commented Professor Anna Dominiczak, Glasgow University's vice-principal and head of the College of Medical, Veterinary and Life Sciences.

"This so-called ‘molecular pathology' is revealing significant variation in diseases which by standard classifications, for example by a pathologist using a microscope, have been indistinguishable."


For information and advice about claiming compensation for an industrial disease, contact Thompsons, the leading personal injury firm in Scotland, click here.

Claim Now